Trial
NCT04568304
A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Collaborators
—
Condition
Locally Advanced or Metastatic Urothelial Carcinoma
Intervention
Toripalimab Injection
Why stopped
This study was not conducted
Provenance
Dataset: 2026-07-10 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-09